TBIO announces $2.375 million private placement financing
Transgenomic announced it has raised gross proceeds of $2.375 million in a private placement financing with a syndicate of new and existing institutional and other accredited investors. The Company’s common shares were priced at $3.25 per share. October 22, 2014